{"title":"Summary Information","content":"\t\t<h3><p>Tranq:  The Deadly Combination of Xylazine, Methamphetamine, and Fentanyl<\/p>\r\n<\/h3>\n\t\t<div class=\"detailDisplay\">\t\t<div class=\"container-fluid summary\">\n\t\t\t\t\t\t<table class=\"table table-summary\"><tbody>\n\t\t\t\t\t\t\t<tr data-id=\"submission-field-8205\">\n\t\t\t\t\t<th>Workshop Title<\/th>\n\t\t\t\t\t<td>Tranq:  The Deadly Combination of Xylazine, Methamphetamine, and Fentanyl<\/td>\n\t\t\t\t<\/tr>\n\t\t\t\t\t\t\t\t<tr data-id=\"submission-field-8207\">\n\t\t\t\t\t<th>Brief Description of Presentation<\/th>\n\t\t\t\t\t<td>There is a rapidly expanding crisis in the United States involving a psychoactive forms of fentanyl and a new street drug, Xylazine. Over the past year, thousands of overdoses have been reported. While efforts to stop the sales and import of \"Tranq\", the drug presents a serious public health risk of potentially wider impact than the original opioid crisis. This presentation will review the latest neurobiological research on Xylazine, fentanyl, methamphetamine, and other street drugs, their legal status, and adverse effects. Drug testing requirements, management of \"Tranq\" overdose and other street drugs toxicities will also be a part of our discussions.<\/td>\n\t\t\t\t<\/tr>\n\t\t\t\t\t\t\t\t<tr data-id=\"submission-field-8208\">\n\t\t\t\t\t<th>Workshop Type<\/th>\n\t\t\t\t\t<td> Prevention<br \/>Recovery<br \/>Treatment<\/td>\n\t\t\t\t<\/tr>\n\t\t\t\t\t\t\t\t<tr data-id=\"submission-field-8209\">\n\t\t\t\t\t<th>Workshop Length<\/th>\n\t\t\t\t\t<td> 3 Hour<\/td>\n\t\t\t\t<\/tr>\n\t\t\t\t\t\t\t<\/tbody><\/table>\n\t\t<\/div>\n\t\t<\/div>\n\t\t"}